Advertisement

Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis

Published:August 25, 2009DOI:https://doi.org/10.1016/j.plefa.2009.04.009

      Abstract

      Spice active principles are reported to have anti-diabetic, anti-hypercholesterolemic, antilithogenic, anti-inflammatory, anti-microbial and anti-cancer properties. In our previous report we have shown that spices and their active principles inhibit 5-lipoxygenase and also formation of leukotriene C4. In this study, we report the modulatory effect of spice active principles viz., eugenol, capsaicin, piperine, quercetin, curcumin, cinnamaldehyde and allyl sulphide on in vitro human platelet aggregation. We have demonstrated that spice active principles inhibit platelet aggregation induced by different agonists, namely ADP (50μM), collagen (500μg/ml), arachidonic acid (AA) (1.0mM) and calcium ionophore A-23187 (20μM). Spice active principles showed preferential inhibition of arachidonic acid-induced platelet aggregation compared to other agonists. Among the spice active principles tested, eugenol and capsaicin are found to be most potent inhibitors of AA-induced platelet aggregation with IC50 values of 0.5 and 14.6μM, respectively. The order of potency of spice principles in inhibiting AA-induced platelet aggregation is eugenol>capsaicin>curcumin>cinnamaldehyde>piperine>allyl sulphide>quercetin. Eugenol is found to be 29-fold more potent than aspirin in inhibiting AA-induced human platelet aggregation. Eugenol and capsaicin inhibited thromboxane B2 (TXB2) formation in platelets in a dose-dependent manner challenged with AA apparently by the inhibition of the cyclooxygenase (COX-1). Eugenol-mediated inhibition of platelet aggregation is further confirmed by dose-dependent decrease in malondialdehyde (MDA) in platelets. Further, eugenol and capsaicin inhibited platelet aggregation induced by agonists—collagen, ADP and calcium ionophore but to a lesser degree compared to AA. These results clearly suggest that spice principles have beneficial effects in modulating human platelet aggregation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cecil R.P.
        • Susan H.
        • Eleftherios P.D.
        • George S.
        • David M.G.
        The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications of protection against coronary heart disease.
        Clin. Chim. Acta. 1995; 235: 207-219
        • Ruggeri Z.M.
        Platelets in atherothrombosi.
        Nat. Med. 2002; 8: 1127-1234
        • Buhl A.M.
        • Johnson N.L.
        • Dhanashekaran N.
        • Johnson G.L.
        12 and Gβ13 stimulate rho-dependent stress fiber formation and focal adhesion assembly.
        J. Biol. Chem. 1995; 270: 24631-24634
        • Offermanns S.
        • Toombs C.F.
        • Hu Y.H.
        • Simon M.I.
        Defective platelet activation in Gαq-deficient mice.
        Nature. 1997; 389: 183-186
        • Patrono C.
        • Coller B.
        • Fitz Gerald G.A.
        • Hirsh J.
        • Roth G.
        Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
        Chest. 2004; 126: 234S-264S
        • Antithrombotic Trialists’ Collaboration (ATC)
        Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
        Br. Med. J. 2002; 324: 71-86
      1. Lepäntalo, A., individual variation in in vitro efficacy of antiplatelet medication—aspirin and clopidogrel. Academic Dissertation, Department of Medicine, Institute of Clinical Medicine, Faculty of Medicine, University of Helsinki, Finland, 2007.

        • Helgason C.M.
        • Bolin K.M.
        • Hoff J.A.
        • Winkler S.R.
        • Mangat A.
        • Tortorice K.L.
        • Brace L.D.
        Development of aspirin resistance in persons with previous ischemic stroke.
        Stroke. 1994; 25: 2331-2336
        • Gum P.A.
        • Kottke-Marchant K.
        • Welsh P.A.
        • White J.
        • Topol E.J.
        A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.
        J. Am. Coll. Cardiol. 2003; 41: 961-965
        • Golanski J.
        • Golanski R.
        • Iwaszkiewicz A.
        • Chlopicki S.
        • Gresner P.
        • Watala C.
        Resistance to aspirin in patients after coronary artery bypass grafting is transient. Impact on the monitoring of aspirin antiplatelet therapy.
        Ther. Drug Monit. 2005; 27: 484-490
        • Hertog M.G.
        • Feskens E.J.
        • Hollman P.C.
        • Katan M.B.
        • Kromhout D.
        Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study.
        Lancet. 1993; 342: 1007-1011
        • Vita J.A.
        Polyphenols and cardiovascular disease: effects on endothelial and platelet function.
        Am. J. Clin. Nutr. 2005; 81: 292S-297S
        • Rein D.
        • Paglieroni T.G.
        • Wun T.
        • Pearson D.A.
        • Schmitz H.H.
        • Gosselin R.
        • Keen C.L.
        Cocoa inhibits platelet activation and function.
        Am. J. Clin. Nutr. 2000; 72: 30-35
        • Freedman J.E.
        • Parker III, C.
        • Li L.
        • Perlman J.A.
        • Frei B.
        • Ivanov V.
        • Deak L.R.
        • Iafrati M.D.
        • Folts J.D.
        Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release.
        Circulation. 2001; 103: 2792-2798
        • Srivastava K.C.
        • Bordia A.
        • Verma S.K.
        Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets.
        Prostaglandins Leukot. Essent. Fatty Acids. 1995; 52: 223-227
        • Shah B.H.
        • Nawaz Z.
        • Pertani S.A.
        • Roomi A.
        • Mahmood H.
        • Saeed S.A.
        • Gilani A.H.
        Inhibitory effect of curcumin, a food spice from turmeric, on platelet activating factor-and arachidonic acid mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling.
        Biochem. Pharmacol. 1999; 58: 1167-1172
        • Srivastava K.C.
        • Malhotra N.
        Acetyl eugenol, component of oil of cloves (Syzigium aromaticum) inhibits platelet aggregation and alters arachidonic acid metabolism in human blood platelets.
        Prostaglandins Leukot. Essent. Fatty Acids. 1991; 42: 73-81
        • Chen S.J.
        • Wang M.H.
        • Chen I.J.
        Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate.
        Gen. Pharmacol. 1996; 27: 629-6333
        • Satyaprasad N.
        • Raghavendra R.
        • Lokesh B.R.
        • Naidu K.A.
        Spice phenolics inhibit human PMNL 5-lipoxygenase.
        Prostaglandins Leukot. Essent. Fatty Acids. 2004; 70: 521-528
        • Raghavendra H.
        • Diwakar B.T.
        • Lokesh B.R.
        • Naidu K.A.
        Eugenol active principle of clove inhibit 5-lipoxygenase and leukotriene-C4 in human PMNLs.
        Prostaglandins Leukot. Essent. Fatty Acids. 2006; 74: 23-27
        • Hamilton J.G.
        • Karol R.J.
        High performance liquid chromatography (HPLC) of arachidonic acid metabolites.
        Prog. Lipid Res. 1982; 21: 155-170
        • Brouard C.
        • Pascaud M.
        Effects of moderate dietary supplementations with n-3 fatty acids on macrophage and lymphocyte phospholipids and macrophage eicosanoid synthesis in the rat.
        Biochem. Biphys. Acta. 1990; 1047: 19-20
        • David R.J.
        • Barbara B.
        Analysis of Cardiac membrane phospholipids peroxidation kinetics as malondialdehyde: non-specificity of thiobarbituric acid-reactivity.
        Lipids. 1988; 23: 452-458
        • Patrono C.
        Aspirin resistance: definition, mechanisms and clinical read-outs.
        J. Thromb. Haemostasis. 2003; 1: 1710-1713
        • Takenaga M.
        • Hirai A.
        • Terano T.
        • Tamura Y.
        • Kitgawa H.
        • Yoshida S.
        In vitro effect of cinnamaldehyde, a main component of cinnamoni cortex.
        Chem. Pharm. Bull. 1975; 23: 941-947
        • Shattil S.J.
        • Ginsberg M.H.
        • Brugge J.S.
        Adhesive signaling in platelets.
        Curr. Opin. Cell Biol. 1994; 6: 695-704
        • Jingqun H.
        • Siwang W.
        • Xiaoxing L.
        • Yanhua X.
        • Xinyou S.
        Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents.
        Thromb. Res. 2007; 119: 337-342
        • Srinivasan K.
        Role of spices beyond food flavoring: nutraceuticals with multiple health effects.
        Food Rev. Int. 2005; 21: 167-188